drugset / Trial / NCT00158652

Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC

NCT00158652 ↗

Phase 3 Completed 840 enrolled Groupe Oncologie Radiotherapie Tete et Cou
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multicentric randomized phase III trial comparing conventional radiotherapy with concomitant chemotherapy versus accelerated radiotherapy with concomitant chemotherapy versus very accelerated radiotherapy in patients with stage III-IV head and neck squamous cell carcinoma. The main end point is the event free survival.

Timeline

Start
2000-03
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 70 mg/m2 —
Subject fluorouracil Small molecule 600 mg/m2 —